Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Odyssey Therapeutics, Inc. - Common Stock (NQ:ODTX)

19.60 +0.52 (+2.73%)
Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Odyssey Therapeutics, Inc. - Common Stock

News headline image
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026
Topline induction results expected in the second half of 2027 
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Odyssey Therapeutics Inc
Via GlobeNewswire
News headline image
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
From Odyssey Therapeutics Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.